Amber

Infectious Disease Epidemiologist @JohnsHopkinsSPH. Interested in translational epidemiology, infectious disease. Views are solely my own.

[Amber @EpiAmber]

Happy to contribute to this Covid Year in Review with colleagues at Johns Hopkins Bloomberg School of Public Health. A look back and a look forward. https://t.co/NxqfMePtQ8

[Amber @EpiAmber]

Was wonderful to meet in person for the the Eurogin 2022 conference. Lucky to have colleagues like @hilaryarobbins @DrKKuhs @EleniRettig as fellow speakers for this head and neck cancer session

[Amber @EpiAmber]

See our press briefing discussing BA2 variant, what is to come in year three of the pandemic and how violence in Ukraine increases COVID-19 transmission https://t.co/s9YbnqhPrU via @YouTube

[Amber @EpiAmber]

Enjoyed speaking with @FUTURUMCareers about epidemiology, my research journey and amazing collaborators. Lots of opportunities for young people interested in making a difference in public health.

[FUTURUMCareers @FUTURUMCareers]

Professor Amber D’Souza, based @JohnsHopkinsSPH in the US, is working to develop improved means of detecting oral HPV16 infection. The findings could help detect oropharyngeal cancers caused by HPV earlier and reduce cancer incidence
https://t.co/4GxCS6TMtv

[Amber @EpiAmber]

@hilaryarobbins So lucky to have worked with you Hilary 🙂

[Johns Hopkins Bloomberg School of Public Health @JohnsHopkinsSPH]

"I'm excited by the new CDC guidance around masks. I think it is time to update the policy and follow the changing signs of this pandemic," said @EpiAmber. https://t.co/eOR33S922P

[Amber @EpiAmber]

Nice job by @AACR on this summary of impacts of COVID on cancer. Includes patient perspective video and infographics that drive home how far we have come and how the past two years impacted many living with cancer. https://t.co/PAXVuBxVJv

[Johns Hopkins Epidemiology @JohnsHopkinsEPI]

"Going out and intentionally seeking this infection does not serve the purpose of getting it over with," says @EpiAmber. "It doesn’t protect you long term from infection, because those antibodies from getting COVID don’t last that long." https://t.co/6wka3UTzI8

[Amber @EpiAmber]

Enjoyed talking with Amy McKeever @NatGeo about the terrible milestone we are approaching with COVID-19 having killed nearly 5 million people https://t.co/o2UU9OytNI

[Stephanie Desmon @sdesmon]

This was an interesting chat I had with @EpiAmber and @DavidWDowdy about how what we know about herd immunity doesn't seem to apply to #COVID19. Take a listen.

[Amber @EpiAmber]

Rethinking Herd Immunity and the Covid-19 Response End Game | Johns Hopkins Bloomberg School of Public Health https://t.co/zpfGYX90Br

[Amber @EpiAmber]

So proud of my graduate student @YuehanZhang2 for this wonderful analysis on Expect impact of HPV Vaccination on Oropharynx Cancer Incidence, 2020-2045 https://t.co/SWJrvLFucF via @JAMAOnc part of @JAMANetwork

[Amber @EpiAmber]

Delta variant doubles the risk of hospitalization, study confirms https://t.co/FZPjhvsYi5 via @nbcnews

[Amber @EpiAmber]

EXPLAINER: What to Know About the Delta and Delta Plus Coronavirus Variants https://t.co/Ht5PWi3oxx

[Johns Hopkins Epidemiology @JohnsHopkinsEPI]

"If we don't get high [vaccine] uptake among all groups, we're not going to be able to reduce transmission," cautioned @EpiAmber. https://t.co/EH79GgC4MN

[Justin Lessler @JustinLessler]

Thrilled our paper on household #COVID19 risk and in person schooling is out in @ScienceMagazine rapid release!
https://t.co/spIdh4DLMk

w/ MK Grabowski, @andrewazman, @khgrantz, @Lizstuartdc, @CJEMetcalf et al.

Some highlights (repetatuve w/ https://t.co/cScCdUYF2Y ) (1/n)

[Amber @EpiAmber]

Enjoyed chatting with NY Times about what to consider when traveling and concern about endangering others. https://t.co/92BgKOMpGp

[Amber @EpiAmber]

See our video on @FacebookWatch about "How Close Are We to Herd Immunity With Vaccine Rollouts?" https://t.co/USs7Bk1FBA

[Amber @EpiAmber]

We updated our article on Herd Immunity and how we can achieve it. This is a race of vaccine verse virus, but we can win that race.
https://t.co/nNNZMoFBOB

[Ellen MacKenzie @EllenJMacKenzie]

This week's upcoming Dean's Lecture with @EpiAmber will focus on translational epidemiology, or using epidemiological results to improve health outcomes and help shape policies—quite a timely topic. Mark your calendars!

📅 March 10
🕙 4-5pm EST
🔗 https://t.co/4MYA7VmC6f